155 related articles for article (PubMed ID: 23160065)
1. The early detection research network: 10-year outlook.
Srivastava S
Clin Chem; 2013 Jan; 59(1):60-7. PubMed ID: 23160065
[TBL] [Abstract][Full Text] [Related]
2. The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers.
Feng Z; Kagan J; Pepe M; Thornquist M; Ann Rinaudo J; Dahlgren J; Krueger K; Zheng Y; Patriotis C; Huang Y; Sorbara L; Thompson I; Srivastava S
Clin Chem; 2013 Jan; 59(1):68-74. PubMed ID: 23193062
[TBL] [Abstract][Full Text] [Related]
3. The Early Detection Research Network: A National Infrastructure to Support the Discovery, Development, and Validation of Cancer Biomarkers.
Srivastava S; Wagner PD
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2401-2410. PubMed ID: 32357955
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics: biomarkers of early detection.
Crichton DJ; Mattmann CA; Thornquist M; Anton K; Hughes JS
Cancer Biomark; 2010; 9(1-6):511-30. PubMed ID: 22112493
[TBL] [Abstract][Full Text] [Related]
5. New cancer biomarkers deriving from NCI early detection research.
Verma M; Srivastava S
Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
[TBL] [Abstract][Full Text] [Related]
6. The impact of the lung EDRN-CVC on Phase 1, 2, & 3 biomarker validation studies.
Kammer MN; Deppen SA; Antic S; Jamshedur Rahman SM; Eisenberg R; Maldonado F; Aldrich MC; Sandler KL; Landman B; Massion PP; Grogan EL
Cancer Biomark; 2022; 33(4):449-465. PubMed ID: 35491773
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN.
Liu Y; Kaur S; Huang Y; Fahrmann JF; Rinaudo JA; Hanash SM; Batra SK; Singhi AD; Brand RE; Maitra A; Haab BB
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2513-2523. PubMed ID: 32532830
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers in cancer screening: a public health perspective.
Srivastava S; Gopal-Srivastava R
J Nutr; 2002 Aug; 132(8 Suppl):2471S-2475S. PubMed ID: 12163714
[TBL] [Abstract][Full Text] [Related]
9. Adding Rigor to Biomarker Evaluations-EDRN Experience.
Feng Z; Pepe MS
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2575-2582. PubMed ID: 33172885
[TBL] [Abstract][Full Text] [Related]
10. Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools.
Kagan J; Srivastava S; Barker PE; Belinsky SA; Cairns P
Cancer Res; 2007 May; 67(10):4545-9. PubMed ID: 17510378
[TBL] [Abstract][Full Text] [Related]
11. Early detection of cancer. Abstracts and proceedings of the National Cancer Institute's Early Detection Research Network Workshop and the Associate Program, June 13, 2004, Bethesda, Maryland, USA.
Cancer Biomark; 2005; 1(2-3):109-205. PubMed ID: 17192036
[No Abstract] [Full Text] [Related]
12. Systematic, evidence-based discovery of biomarkers at the NCI.
Prensner JR; Chinnaiyan AM; Srivastava S
Clin Exp Metastasis; 2012 Oct; 29(7):645-52. PubMed ID: 22868876
[TBL] [Abstract][Full Text] [Related]
13. The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis.
Paradiso A; Mangia A; Orlando C; Verderio P; Belfiglio M; Marchetti A; Bertario L; Chiappetta G; Gion M; Tonini GP; Podo F; Vocaturo A; Silvestrini R; Romani M; Belloni E; Cavallo D; Ulivi P; Tommasi S; Steffan A; Russo A; Alessio M; Calistri D; Zancan M; Parrela P; Broggini M; Giuseppe A; Buttitta F; Finocchiaro G; Mazzocco K; Veronesi G; Landuzzi L; Benevolo M; Mariani L; De Marco F; Venuti A; Giannelli G; Quaranta M; Trojano V
Int J Biol Markers; 2009; 24(3):119-29. PubMed ID: 19787622
[TBL] [Abstract][Full Text] [Related]
14. Joint National Cancer Institute-Food and Drug Administration workshop on research strategies, study designs, and statistical approaches to biomarker validation for cancer diagnosis and detection.
Maruvada P; Srivastava S
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1078-82. PubMed ID: 16775163
[TBL] [Abstract][Full Text] [Related]
15. Cancer biomarker discovery and development in gastrointestinal cancers: early detection research network-a collaborative approach.
Srivastava S
Gastrointest Cancer Res; 2007; 1(4 Suppl 2):S60-3. PubMed ID: 19360150
[TBL] [Abstract][Full Text] [Related]
16. The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology.
Grizzle WE; Semmes OJ; Basler J; Izbicka E; Feng Z; Kagan J; Adam BL; Troyer D; Srivastava S; Thornquist M; Zhang Z; Thompson IM
Urol Oncol; 2004; 22(4):337-43. PubMed ID: 15283893
[TBL] [Abstract][Full Text] [Related]
17. The long journey of cancer biomarkers from the bench to the clinic.
Pavlou MP; Diamandis EP; Blasutig IM
Clin Chem; 2013 Jan; 59(1):147-57. PubMed ID: 23019307
[TBL] [Abstract][Full Text] [Related]
18. Trends in biomarker research for cancer detection.
Srinivas PR; Kramer BS; Srivastava S
Lancet Oncol; 2001 Nov; 2(11):698-704. PubMed ID: 11902541
[TBL] [Abstract][Full Text] [Related]
19. Validation of new cancer biomarkers: a position statement from the European group on tumor markers.
Duffy MJ; Sturgeon CM; Sölétormos G; Barak V; Molina R; Hayes DF; Diamandis EP; Bossuyt PM
Clin Chem; 2015 Jun; 61(6):809-20. PubMed ID: 25882892
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers: diagnostic highlights and surrogate end points. Cambridge Healthtech Institute's biomarker series: biomarker validation: bringing discovery to the clinic & cancer biomarkers: from discovery to clinical practice. May 3-5, 2004, Philadelphia, Pennsylvania, USA.
Levenson VV
Pharmacogenomics; 2004 Jul; 5(5):459-61. PubMed ID: 15212582
[No Abstract] [Full Text] [Related]
[Next] [New Search]
